(Q39051459)

8 September 2017

Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell (English)

1 reference

8 September 2017

1 reference

D W Cui

1

1 reference

8 September 2017

Y J Cheng

series ordinal

2

1 reference

8 September 2017

S W Jing

series ordinal

3

1 reference

8 September 2017

G G Sun

series ordinal

4

1 reference

8 September 2017

29 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

35

1 reference

8 September 2017

4

1 reference

8 September 2017

3017-3024

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1389-4

8 September 2017

0 references

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G2 dysregulation in human oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1389-4

Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24293374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characterisation of human cyclin G1 and G2: DNA damage inducible genes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24293374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24293374

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-1389-4

1 reference

8 September 2017

1 reference